These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 21981945)
21. Chemoradionuclide therapy with 186Re-labeled liposomal doxorubicin in combination with radiofrequency ablation for effective treatment of head and neck cancer in a nude rat tumor xenograft model. Soundararajan A; Dodd GD; Bao A; Phillips WT; McManus LM; Prihoda TJ; Goins BA Radiology; 2011 Dec; 261(3):813-23. PubMed ID: 22025735 [TBL] [Abstract][Full Text] [Related]
22. Noninvasive Imaging of Liposomal Delivery of Superparamagnetic Iron Oxide Nanoparticles to Orthotopic Human Breast Tumor in Mice. Kato Y; Zhu W; Backer MV; Neoh CC; Hapuarachchige S; Sarkar SK; Backer JM; Artemov D Pharm Res; 2015 Nov; 32(11):3746-3755. PubMed ID: 26078000 [TBL] [Abstract][Full Text] [Related]
23. Pretreatment 18F-FAZA PET predicts success of hypoxia-directed radiochemotherapy using tirapazamine. Beck R; Röper B; Carlsen JM; Huisman MC; Lebschi JA; Andratschke N; Picchio M; Souvatzoglou M; Machulla HJ; Piert M J Nucl Med; 2007 Jun; 48(6):973-80. PubMed ID: 17536108 [TBL] [Abstract][Full Text] [Related]
24. Doxorubicin induces apoptosis in Jurkat cells by mitochondria-dependent and mitochondria-independent mechanisms under normoxic and hypoxic conditions. Mendivil-Perez M; Velez-Pardo C; Jimenez-Del-Rio M Anticancer Drugs; 2015 Jul; 26(6):583-98. PubMed ID: 25734830 [TBL] [Abstract][Full Text] [Related]
25. Increase of therapeutic effects by treating melanoma with targeted combinations of c-myc antisense and doxorubicin. Pastorino F; Mumbengegwi DR; Ribatti D; Ponzoni M; Allen TM J Control Release; 2008 Feb; 126(1):85-94. PubMed ID: 18166243 [TBL] [Abstract][Full Text] [Related]
26. New potential therapy for orthotopic bladder carcinoma by combining HVJ envelope with doxorubicin. Kawano H; Komaba S; Yamasaki T; Maeda M; Kimura Y; Maeda A; Kaneda Y Cancer Chemother Pharmacol; 2008 May; 61(6):973-8. PubMed ID: 17653716 [TBL] [Abstract][Full Text] [Related]
27. A metronomic schedule of cyclophosphamide combined with PEGylated liposomal doxorubicin has a highly antitumor effect in an experimental pulmonary metastatic mouse model. Shiraga E; Barichello JM; Ishida T; Kiwada H Int J Pharm; 2008 Apr; 353(1-2):65-73. PubMed ID: 18155369 [TBL] [Abstract][Full Text] [Related]
28. Ultrasound improves the uptake and distribution of liposomal Doxorubicin in prostate cancer xenografts. Eggen S; Afadzi M; Nilssen EA; Haugstad SB; Angelsen B; Davies Cde L Ultrasound Med Biol; 2013 Jul; 39(7):1255-66. PubMed ID: 23643054 [TBL] [Abstract][Full Text] [Related]
29. Accelerated blood clearance of PEGylated liposomes upon repeated injections: effect of doxorubicin-encapsulation and high-dose first injection. Ishida T; Atobe K; Wang X; Kiwada H J Control Release; 2006 Oct; 115(3):251-8. PubMed ID: 17045355 [TBL] [Abstract][Full Text] [Related]
30. Combination therapy with gefitinib and doxorubicin inhibits tumor growth in transgenic mice with adrenal neuroblastoma. Kawano K; Hattori Y; Iwakura H; Akamizu T; Maitani Y Cancer Med; 2013 Jun; 2(3):286-95. PubMed ID: 23930205 [TBL] [Abstract][Full Text] [Related]
31. Therapeutic efficacy and microSPECT/CT imaging of 188Re-DXR-liposome in a C26 murine colon carcinoma solid tumor model. Chang YJ; Chang CH; Yu CY; Chang TJ; Chen LC; Chen MH; Lee TW; Ting G Nucl Med Biol; 2010 Jan; 37(1):95-104. PubMed ID: 20122674 [TBL] [Abstract][Full Text] [Related]
32. In vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphoma. Lopes de Menezes DE; Pilarski LM; Allen TM Cancer Res; 1998 Aug; 58(15):3320-30. PubMed ID: 9699662 [TBL] [Abstract][Full Text] [Related]
33. Dynamic contrast enhanced MRI detects changes in vascular transport rate constants following treatment with thermally-sensitive liposomal doxorubicin. Fite BZ; Kheirolomoom A; Foiret JL; Seo JW; Mahakian LM; Ingham ES; Tam SM; Borowsky AD; Curry FE; Ferrara KW J Control Release; 2017 Jun; 256():203-213. PubMed ID: 28395970 [TBL] [Abstract][Full Text] [Related]
34. Multiple injections of pegylated liposomal Doxorubicin: pharmacokinetics and therapeutic activity. Charrois GJ; Allen TM J Pharmacol Exp Ther; 2003 Sep; 306(3):1058-67. PubMed ID: 12808004 [TBL] [Abstract][Full Text] [Related]
35. The antitumor activity of doxorubicin against drug-resistant murine carcinoma is enhanced by oral administration of a synthetic staurosporine analogue, CGP 41251. Killion JJ; Beltran P; O'Brian CA; Yoon SS; Fan D; Wilson MR; Fidler IJ Oncol Res; 1995; 7(9):453-9. PubMed ID: 8835289 [TBL] [Abstract][Full Text] [Related]
36. Improvement in the drug delivery and anti-tumor efficacy of PEGylated liposomal doxorubicin by targeting RNA aptamers in mice bearing breast tumor model. Moosavian SA; Abnous K; Badiee A; Jaafari MR Colloids Surf B Biointerfaces; 2016 Mar; 139():228-36. PubMed ID: 26722819 [TBL] [Abstract][Full Text] [Related]
37. Noninvasive monitoring of radiotherapy-induced microvascular changes using dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) in a colorectal tumor model. Ceelen W; Smeets P; Backes W; Van Damme N; Boterberg T; Demetter P; Bouckenooghe I; De Visschere M; Peeters M; Pattyn P Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1188-96. PubMed ID: 16457965 [TBL] [Abstract][Full Text] [Related]
38. Differentiation between hypoxic and non-hypoxic experimental tumors by dynamic contrast-enhanced magnetic resonance imaging. Gulliksrud K; Øvrebø KM; Mathiesen B; Rofstad EK Radiother Oncol; 2011 Mar; 98(3):360-4. PubMed ID: 21262548 [TBL] [Abstract][Full Text] [Related]
39. Hypoxia imaging with Melsens E; De Vlieghere E; Descamps B; Vanhove C; Kersemans K; De Vos F; Goethals I; Brans B; De Wever O; Ceelen W; Pattyn P Radiat Oncol; 2018 Mar; 13(1):39. PubMed ID: 29514673 [TBL] [Abstract][Full Text] [Related]